INAR Approach to Validation of Surrogate Endpoints

Our Findings Help Inform You on Next Step Decision-Making and Planning for Your Drug or Medical Device Our Approach Information from the validation of surrogate endpoints is used for decision-making at the company level or by HTA agencies for reimbursement. Our approach for validation of surrogate

more

Value-Based Strategy for Medical Devices

Value-Driven Health Care There is a growing recognition of value demonstration and HTA for procurement and reimbursement of medical devices in hospitals and health systems alike. In contrast to a solely price-based strategy, value-based payment strategies incorporate measures such as outcomes (including health,

more

Public Procurement of Medical Technologies in Hospitals in Poland

Expert Discussion on Public Procurement of Medical Technologies in Hospitals in Poland by Dziennik Gazeta Prawna Karolina Skóra, COO at Arcana Institute, recently participated in a panel discussion on the procurement of medical technologies for hospitals. The discussion was hosted and

more

Arcana Institute at ISPOR Glasgow 4-8 November 2017

Arcana Institute will be at the ISPOR 20th Annual European Congress in Glasgow, Scotland on 4-8 November 2017 Visit us during poster author discussions! We will have 7 posters on display and will be happy to meet you in person. If

more